Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: Case report

Journal of Neuro-Oncology

Volumn 93, Issue 3, 2009, Pages 409-412

  Torcuator, Roy ^a   Zuniga, Richard ^a   Loutfi, Randa ^a   Mikkelsen, Tom ^a,b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Bevacizumab; Brainstem; Diffuse chemotherapy; Glioma; Irinotecan

Indexed keywords

BEVACIZUMAB; IRINOTECAN; TEMOZOLOMIDE;

ADJUVANT THERAPY; ADULT; ARTICLE; ATAXIA; BRAIN STEM TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIPLOPIA; DRUG WITHDRAWAL; DYSPHAGIA; FATIGUE; FEMALE; GENERAL CONDITION IMPROVEMENT; GLIOMA; HEADACHE; HOARSENESS; HUMAN; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGRESSION FREE SURVIVAL; RADIATION DOSE; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN STEM NEOPLASMS; CAMPTOTHECIN; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY;

EID: 67349215184     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9782-3     Document Type: Article

References (26)

1. Packer RJ (1999) Brain tumors in children. Arch Neurol 56(4):421-425. doi: 10.1001/archneur.56.4.421
2. Freeman CR, Farmer JP (1998) Pediatric brain stem gliomas: A review. Int J Radiat Oncol Biol Phys 40(2):265-271. doi: 10.1016/ S0360-3016(97)00572-5
3. Rubin G, Michowitz S, Horev G, Herscovici Z, Cohen IJ, Shuper A, Rappaport ZH (1998) Pediatric brain stem gliomas: An update. Childs Nerv Syst 14(4-5):167-173. doi: 10.1007/s003810050205
4. Guillamo JS, Monjour A, Taillandier L, Devaux B, Varlet P, Haie-Meder C, Defer GL, Maison P, Mazeron JJ, Cornu P, Delattre JY, Association des Neuro-Oncoloques d'Expression Francoise (ANOCEF) (2001) Brainstem gliomas in adults: Prognostic factors and classification. Brain 124(Pt 12):2528-2539. doi: 10.1093/brain/124.12.2528
5. Massimino M, Spreafico F, Biassoni V, Simonetti F, Riva D, Trecate G, Giombini S, Poggi G, Pecori E, Pignoli E, Casanova M, Ferrari A, Meazza C, Luksch R, Terenziam M, Cefalo G, Podda M, Polastri D, Clerici CA, Fossati-Bellani F, Gondola L (2008) Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. J Neurooncol 87(3):355-361. doi: 10.1007/s11060-008-9525-5
6. Landolfi JC, Thaler HT, DeAngelis LM (1998) Adult brainstem gliomas. Neurology 51(4):1136-1139
7. Selvapandian S, Rajshekhar V, Chandy MJ (1999) Brainstem glioma: comparative study of clinico-radiological presentation, pathology and outcome in children and adults. Acta Neurochir (Wien) 141(7):721-726. doi: 10.1007/s007010050367 (discussion 726-727)
8. Epstein F, Constantini S (1996) Practical decisions in the treatment of pediatric brain stem tumors. Pediatr Neurosurg 24(1):24-34. doi: 10.1159/ 000121011
9. Schild SE, Stafford SL, Brown PD, Wood CP, Scheithauer BW, Schombert PJ, Wong WW, Lyons MK, Shaw EG (1998) The results of radiotherapy for brainstem tumors. J Neurooncol 40(2):171-177. doi: 10.1023/ A:1006193306286
10. Freeman CR, Perilongo G (1999) Chemotherapy for brain stem gliomas. Childs Nerv Syst 15(10):545-553. doi: 10.1007/s003810050542
11. Shuper A, Kornreich L, Loven D, Michowitz S, Schwartz M, Cohen IJ (1998) Diffuse brain stem gliomas. Are we improving outcome? Childs Nerv Syst 14(10):578-581. doi: 10.1007/s003810050275
12. Bouffet E, Khelfaoui F, Philip I, Biron P, Brunet-Mentigny M, Philip T (1997) High-dose carmustine for high-grade gliomas in childhood. Cancer Chemother Pharmacol 39(4):376-379. doi: 10.1007/s002800050586
13. Allen JC, Siffert J (1996) Contemporary chemotherapy issues for children with brainstem gliomas. Pediatr Neurosurg 24(2):98-102. doi: 10.1159/ 000121024
14. Wolff JE, Westphal S, Molenkamp G, Gnekow A, Warmuth-Metz M, Rating D, Kuehl J (2002) Treatment of paediatric pontine glioma with oral trophosphamide and etoposide. Br J Cancer 87(9):945-949. doi: 10.1038/ sj.bjc.6600552
15. Vredenburgh JJ, Desjardins A, Herndon JEII, Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathosumetee S, Gururangan S, Wagner M, Bigner DD, Friedman AH, Friedman HS (2007) Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res 13(4):1253-1259. doi: 10.1158/1078-0432.CCR-06-2309
16. Vredenburgh JJ, Desjardins A, Herndon JEII, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathosumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25(30):4722-4729. doi: 10.1200/JCO.2007.12.2440
17. Cloughesy TF, Prados MD, Wen PY, Mikkelsen T, Abrey LE, Hiff D, Yung WK, Maoxia Z, Dimery I, Friedman HS (2008) A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM). J Clin Oncol 26:91s (abstr 2010b)
18. Gururangan S, Chi S, Onar A, Packer R, Young Poussaint T, Gilbertson R, Friedman H, Kun L, Boyett J (2008) Phase II study of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma - a Pediatric Brain Consortium Study (PBTC-022). Neuro Oncol 5:833 (abstract MA-63)
19. Broniscer A, Gajjar A (2004) Supratentorial high-grade astrocytoma and diffuse brainstem glioma: Two challenges for the pediatric oncologist. Oncologist 9:197-206. doi: 10.1634/theoncologist.9-2-197
20. Lu C, Shervington A (2008) Chemoresistance in gliomas. Mol Cell Biochem 312:71-80. doi: 10.1007/s11010-008-9722-8
21. Reddy A, Mapstone T (2000) Brain stem tumors. In: Bernstein M, Berger MS (eds) Neuro-oncology the essentials. Thieme Medical Publishers, Inc, New York, pp 352-386
22. Packer RJ, Prados M, Phillips P, Nicholson HS, Bovett JM, Goldwein J, Rorke LB, Needle MN, Sutton L, Zimmerman RA, Fitz CR, Vezina LG, Etcubanas E, Wallenberg JC, Reaman G, Wara W (1996) Treatment of children with newly diagnosed brainstem gliomas with intravenous recombinant beta-inteferon and hyperfractionated radiation therapy: A Childrens Cancer Group phase I/II study. Cancer 77:2150-2156. doi:10.1002/ (SICI)1097-0142(19960515)77:10<2150::AID-CNCR28>3.0.CO;2-T
23. Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goulmnerova L, Billett AL, Kieran M, Tarbell NJ (2003) A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys 55(5):1182-1185. doi: 10.1016/ S0360-3016(02)04391-2
24. Findlay JL, Zacharoulis S (2005) The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: A historical- and futuristic-perspective. J Neurooncol 75:253-266. doi: 10.1007/s11060-005-6747-7
25. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT (2007) Angiogenesis in brain tumors. Nat Rev Neurosci 8(8):610-622. doi: 10.1038/nrn2175
26. Jain RK (2005) Antiangiogenic therapy for cancer: Current and emerging concepts. Oncology 19(4(Suppl 3)):7-16 (Williston Park)